Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,377,939
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
25,994,308
-
Shares change
-
-179,280
-
Total reported value, excl. options
-
$522,683,040
-
Value change
-
-$2,775,804
-
Number of buys
-
47
-
Number of sells
-
-64
-
Price
-
$20.11
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q4 2020
141 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q4 2020.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25,994,308 shares
of 46,377,939 outstanding shares and own 56.05% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7,144,166 shares), FEDERATED HERMES, INC. (3,225,883 shares), VANGUARD GROUP INC (2,478,027 shares), DIMENSIONAL FUND ADVISORS LP (1,807,385 shares), Invesco Ltd. (1,395,047 shares), STATE STREET CORP (1,283,164 shares), GEODE CAPITAL MANAGEMENT, LLC (574,144 shares), GOLDMAN SACHS GROUP INC (552,880 shares), FULLER & THALER ASSET MANAGEMENT, INC. (546,344 shares), and NORTHERN TRUST CORP (489,320 shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.